Cleared Traditional

K950197 - MICROCO

K950197 is an FDA 510(k) clearance for MICROCO, manufactured by Micro Direct, Inc.. The device is a Class 2 Anesthesiology device with product code CCJ cleared through the Traditional 510(k) pathway after a 638-day FDA review.

K950197 · Micro Direct, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1996
Decision
638d
Days
Class 2
Risk

K950197 is an FDA 510(k) clearance for the MICROCO. Classified as Analyzer, Gas, Carbon-monoxide, Gaseous-phase (product code CCJ), Class II - Special Controls.

Submitted by Micro Direct, Inc. (Auburn, US). The FDA issued a Cleared decision on October 17, 1996 after a review of 638 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1430 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

FDA 510(k) Submission Details - K950197

510(k) Number K950197 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 18, 1995
Decision Date October 17, 1996
Days to Decision 638 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
498d slower than avg
Panel avg: 140d · This submission: 638d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCJ Device Classification - Class 2, Special Controls

Product Code CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase

All 25
Devices cleared under the same product code (CCJ) and FDA review panel - the closest regulatory comparables to K950197.
TABATABA COTESTER
K080278 · Fim Medical · Nov 2008
EC50 TOXCO+ BREATH CARBON MONOXIDE MONITOR
K070259 · Bedfont Scientific, Ltd. · Feb 2008
PICO SMOKERLYZER, MODEL EC-50
K000962 · Bedfont Scientific, Ltd. · Apr 2000
CO BREATH ANALYSIS MODULE & MONOXOL II
K952694 · Bacharach, Inc. · Jan 1996
SPIROLOOP, MODIFICATION
K904633 · Pneumedics, Inc. · Mar 1991
VITALOGRAPH - BREATHCO MONITOR
K902113 · Mcneill Intl., Inc. · Oct 1990
K950197 · MICROCO
Download PDF Micro Direct, Inc.